Febril Nöbet Artı Genetik Epilepsi (Genetic Epilepsy With Febrile Seizure Plus, GEFS+)
Özet
Febril nöbet artı genetik epilepsi (GEFS+), basit ateşli nöbetlerden ağır epileptik ensefalopatilere kadar uzanan değişken bir fenotipik spektruma sahip ailevi bir epilepsi sendromudur. Kalıtımı genellikle otozomal dominant özellik gösterse de, hastalığın genetik temeli oldukça heterojendir ve SCN1A, SCN1B gibi birçok gen mutasyonu ile ilişkilendirilmiştir. Tedavi genellikle antiepileptik ilaçlarla yönetilmekte olup, sodyum kanal blokörlerinin kullanımında dikkatli olunması önerilmektedir; prognoz ise hastadan hastaya değişmekle birlikte büyük çoğunlukta iyi seyirlidir.
Genetic epilepsy with febrile seizures plus (GEFS+) is a familial epilepsy syndrome characterized by a variable phenotypic spectrum ranging from simple febrile seizures to severe epileptic encephalopathies. Although its inheritance pattern is typically autosomal dominant, the genetic basis of the condition is highly heterogeneous and associated with mutations in several genes, including SCN1A and SCN1B. Treatment is generally managed with antiepileptic drugs, with caution advised regarding the use of sodium channel blockers; while the prognosis varies among patients, it is typically favorable for the majority.
Referanslar
Myers KA, Scheffer IE, Berkovic SF. Genetic literacy series: genetic epilepsy with febrile seizures plus. Epileptic Disord. 2018;20(4):232-8.
Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120 ( Pt 3):479-90.
Nordli DR, Pellock JM. Generalized Epilepsy Febrile Seizure Plus (GEFS+). In: Pellock JM, Nordli DR, Sankar R, Wheless JE, editors. Pellock’s Pediatric Epilepsy Diagnosis and Theraphy. 4. ed. 2017. p.305-7.
Zhang YH, Burgess R, Malone JP, et al. Genetic epilepsy with febrile seizures plus: Refining the spectrum. Neurology. 2017;89(12):1210-9.
Panayiotopoulos C. Idiopathic epileptic seizures and syndromes in infancy. In: Panayiotopoulos C, editor. Epileptic Syndromes and Their Treatment; 2010. p. 265-7.
Camfield P, Camfield C. Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+). Epileptic Disord. 2015;17(2):124-33.
Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol. 1999;45(1):75-81.
Riva A, Coppola A, Balagura G, et al. Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation. Epileptic Disord. 2021;23(2):397-401.
Baulac M, Gourfinkel-An I, Baulac S, Leguern E. Myoclonic seizures in the context of generalized epilepsy with febrile seizures plus (GEFS+). Adv Neurol. 2005;95:119-25.
Miller IO, Sotero de Menezes MA. SCN1A Seizure Disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, et al., editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle Copyright © 1993-2021, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.
Scheffer IE, Nabbout R. SCN1A-related phenotypes: Epilepsy and beyond. Epilepsia. 2019;60 Suppl 3:S17-s24.
Skjei KL, Church EW, Harding BN, et al. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. J Neurosurg Pediatr. 2015;16(6):668-74.
Myers KA, Burgess R, Afawi Z et al. De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome. Epilepsia. 2017;58(2):e26-e30.
Binini N, Sancini G, Villa C, et al. Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE). Brain Res. 2017;1677:26-32.
Mantegazza M, Broccoli V. SCN1A/Na(V) 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models. Epilepsia. 2019;60 Suppl 3:S25-s38.
Ito M, Yamakawa K, Sugawara T, Hirose S, Fukuma G, Kaneko S. Phenotypes and genotypes in epilepsy with febrile seizures plus. Epilepsy Res. 2006;70 Suppl 1:S199-205.
Li X, Guo S, Liu K, et al. GABRG2 Deletion Linked to Genetic Epilepsy with Febrile Seizures Plus Affects the Expression of GABA(A) Receptor Subunits and Other Genes at Different Temperatures. Neuroscience. 2020;438:116-36.
Warner TA, Liu Z, Macdonald RL, Kang JQ. Heat induced temperature dysregulation and seizures in Dravet Syndrome/GEFS+ Gabrg2(+/Q390X) mice. Epilepsy Res. 2017;134:1-8.
Wirrel EC, Nickels KC. Electroclinical Syndromes: Infantile Onset. In: Kenneth F. Swaiman SA, Donna M Ferriero, Nina F Schor, Richard S Finkel, Andrea L Gropman, Phillip L Pearl, Michael Shevell, editor. Swaiman's Pediatric Neurology. 6. ed. 2018. p. 1342-3.
Hanaya R, Niantiarno FH, Kashida Y, et al. Vagus nerve stimulation for genetic epilepsy with febrile seizures plus (GEFS(+)) accompanying seizures with impaired consciousness. Epilepsy Behav Case Rep. 2017;7:16-9.
Myers KA, Shevell MI, Sébire G. Sudden unexpected death in GEFS+ families with sodium channel pathogenic variants. Epilepsy Res. 2019;150:66-9.
de Lange IM, Gunning B, Sonsma ACM, et al. Outcomes and comorbidities of SCN1A-related seizure disorders. Epilepsy Behav. 2019;90:252-9.
